Cahill Financial Advisors’s Dentsply Sirona XRAY Stock Holding History

Cahill Financial Advisors’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,500	Closed	-$87K	–	809
2021 Q3	$87K	Buy	+1,500	New	+$92.5K	0.02%	277
2020 Q4	–	Sell	-5,360	Closed	-$235K	–	198
2020 Q3	$235K	Hold	5,360	–	–	0.08%	149
2020 Q2	$237K	Sell	5,360 -13,584	-72%	-$574K	0.09%	144
2020 Q1	$736K	Buy	18,944 +3	+0%	+$153	0.34%	73
2019 Q4	$1.07M	Sell	18,941 -186	-1%	-$10.4K	0.39%	69
2019 Q3	$1.02M	Buy	19,127 +3	+0%	+$161	0.4%	67
2019 Q2	$1.12M	Sell	19,124 -13,259	-41%	-$712K	0.44%	61
2019 Q1	$1.61M	Buy	32,383 +5	+0%	+$220	0.67%	46
2018 Q4	$1.21M	Sell	32,378 -183	-0.6%	-$6.66K	0.6%	49
2018 Q3	$1.23M	Sell	32,561 -6,307	-16%	-$263K	0.54%	48
2018 Q2	$1.7M	Hold	38,868	–	–	0.79%	37
2018 Q1	$1.96M	Buy	38,868 +25,473	+190%	+$1.5M	0.93%	30
2017 Q4	$882K	Buy	+13,395	New	+$852K	0.44%	59

Other funds holding XRAY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Cahill Financial Advisors's XRAY Position: Q4 2021 in Review

Cahill Financial Advisors sold out of Dentsply Sirona (XRAY) in Q4 2021, closing a stake of 1,500 shares — an estimated $87K sold.

Cahill Financial Advisors first reported a position in XRAY in Q4 2017 and held it in 13 quarters. The position peaked at $1.96M in Q1 2018. 544 funds tracked by Wall St. Rank hold XRAY as of Q4 2021.

Cahill Financial Advisors reported no remaining Dentsply Sirona position as of Q4 2021 after selling out during the quarter.
Cahill Financial Advisors sold 1,500 Dentsply Sirona shares in Q4 2021, an estimated $87K.
Cahill Financial Advisors first reported a position in Dentsply Sirona in Q4 2017 and held it in 13 quarters.
Cahill Financial Advisors's Dentsply Sirona position peaked at $1.96M in Q1 2018.
544 funds tracked by Wall St. Rank held Dentsply Sirona as of Q4 2021.

Based on Cahill Financial Advisors's 13F filing for Q4 2021, filed 11 Feb 2022.